/

Bio-Rad Laboratories, Inc.

BIO US

BIO USBio-Rad Laboratories, Inc.

United States Composite

281.02

USD

-9.84

(-3.38%)

-21.77EPS Dil.

-12.88P/E

8.01BMarket Cap

Next Earnings

May 2

Held by Insiders

15.23%

Held by Institutions

81.72%

Short % of Float

1.77%

YTD Yield

-32.53%

3Y Yield

-47.87%

5Y Yield

11.58%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

LT Borrowings

1,198

1,189

1,199

LT Finance Leases

147

177

165

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

11,023

10,447

9,208

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

3,139

3,147

3,048

Cash, Cash Equivalents & STI

1,723

1,759

1,607

Accounts Receivable, Net

492

457

489

Inventories

777

776

781

Total Current Liabilities

582

558

523

Payables & Accruals

379

371

320

ST Debt

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

2.48%

3.42%

-4.68%

Net Income, GAAP

93.58%

81.22%

82.44%

Free Cash Flow

-93.63%

52.55%

172.50%

Total Cash Common Dividend

- -

Total Equity

18.28%

22.90%

-9.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

727

716

747

733

2,923

2022

700

691

681

730

2,802

2023

677

681

632

681

2,671

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

32.77

30.71

131.75

-52.59

142.61

2022

-112.50

-31.05

-5.48

28.08

-121.79

2023

2.33

-39.59

3.65

12.15

-21.82

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Norman D. Schwartz
Full Time Employees: 8,030
Sector: Healthcare
Industry: Medical Devices
Address: 1000 Alfred Nobel Drive Hercules CA United States 94547
CIK: 0000012208
Website: www.bio-rad.com
Business: Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Company News

Yahoo
2 days ago
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%
Zacks
3 days ago
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Yahoo
3 days ago
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Yahoo
6 days ago
OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...
Yahoo
6 days ago
Q4 2023 OncoCyte Corp Earnings Call
Yahoo
8 days ago
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Zacks
8 days ago
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Yahoo
9 days ago
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Tipranks
10 days ago
RBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)
Zacks
22 days ago
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
Yahoo
22 days ago
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
Yahoo
a month ago
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
Yahoo
a month ago
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
Zacks
a month ago
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
Yahoo
a month ago
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition
Zacks
a month ago
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition

Company News

Yahoo
2 days ago
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%
Zacks
3 days ago
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Yahoo
3 days ago
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Yahoo
6 days ago
OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...
Yahoo
6 days ago
Q4 2023 OncoCyte Corp Earnings Call
Yahoo
8 days ago
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Zacks
8 days ago
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Yahoo
9 days ago
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Tipranks
10 days ago
RBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)
Zacks
22 days ago
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
Yahoo
22 days ago
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
Yahoo
a month ago
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
Yahoo
a month ago
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
Zacks
a month ago
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
Yahoo
a month ago
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition
Zacks
a month ago
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition